protein
| Sin3A-associated protein 130kDa, mSin3A  |
|
C-terminal binding protein 1, CTBP1  |
|
Sin3A-associated protein 30kDa, SAP30  |
|
CBF1/RBP-Jkappa  |
|
retinoblastoma-like 1 (p107) and retinoblastoma-like 2 (p130)  |
|
breast cancer 1, early onset, BRCA1  |
|
embryonic ectoderm development, EED  |
|
DNA (cytosine-5-)-methyltransferase 1, Dnmt1  |
|
histone deacetylase 9, HDAC9  |
|
retinoblastoma, Rb and retinoblastoma binding protein 4, RBBP4  |
|
HUS1 checkpoint homolog (S. pombe), HUS1 and RAD9 homolog A (S. pombe), RAD9A  |
|
BCL6 corepressor, BCoR  |
|
Receptor-interacting protein 140, RIP140  |
|
nuclear receptor corepressor 2, NCOR2  |
|
DNA topoisomerase II alpha and beta  |
|
REST corepressor 1, RCOR1  |
|
promyelocytic leukemia, PML  |
|
DNA (cytosine-5-)-methyltransferase 3 alpha, DNMT3A  |
|
TG-interacting factor 2, TGIF2  |
|
YY1 transcription factor, YY1  |
|
FK506 binding protein 3, 25kDa, FKBP25  |
|
protein ETO-2 |
|
EVI-1 and MDS1/EVI1  |
|
v-rel reticuloendotheliosis viral oncogene homolog A (avian), RELA  |
|
hairless homolog (mouse), HR  |
|
MyoD and pRb during skeletal myogenesis  |
|
heat shock 70kDa protein 4, HSPA4  |
|
suppressor of variegation 3-9 homolog 1 (Drosophila), SUV39H1  |
|
sal-like 1 (Drosophila), SALL1  |
|
PEX14 peroxisomal biogenesis factor 14, PEX14 |
|
Proliferating cell nuclear antigen, PCNA  |
|
NF-kappa B  |
|
inhibitor of growth family, member 1, ING1  |
|
androgen receptor, AR  |
|
Replication factor C, RFC  |
|
methyl-CpG binding domain protein 3, MBD3  |
|
tetradecanoyl phorbol acetate induced sequence 7, TIS7 |
|
bromodomain adjacent to zinc finger domain 2A, BAZ2A  |
|
myeloid translocation gene on chromosome 16 protein, MTG16  |
|
DNA (cytosine-5-)-methyltransferase 3-like, DNM3L and DNA (cytosine-5-)-methyltransferase 3 beta, DNMT3B  |
|
ERG-associated protein with SET domain, ESET  |
|
mesoderm induction early response 1 homolog alpha and beta, MIER1alpha and MIER1beta  |
|
EP300 interacting inhibitor of differentiation 2, EID2  |
|
EF-hand calcium binding domain 6, EFCAB6  |
|
Epstein-Barr virus (EBV) nuclear antigen 3C, EBNA3C  |
|
chromodomain helicase DNA binding protein 1, CHD1  |
|
protein inhibitor of activated STAT 4, PIAS4  |
|
metastasis associated 1, MTA1  |
|
chromodomain-Y-like, Cdyl |
|
IkappaBalpha, IKBA  |
|
mortality factor 4 like 2, MORF4L2  |
|
estrogen receptor 1, ESR1  |
|
signal transducer and activator of transcription 1, STAT1 and signal transducer and activator of transcription 2, STAT2  |
|
APEX nuclease (multifunctional DNA repair enzyme) 1, APE1  |
|
transcription factor NF-E4, NFE4  |
|
p68 and p72 DEAD box RNA helicases  |
|
melanoma antigen family A, 1 (directs expression of antigen MZ2-E), MAGEA1  |
|
PHD finger protein 21A, PHF21A  |
|
B-cell CLL/lymphoma 3, BCL3  |
|
sucrose nonfermenting protein 2 homolog, SNF2h  |
|
EP300 interacting inhibitor of differentiation 3, EID3  |
|
regulatory factor X, 1 (influences HLA class II expression), RFX1  |
|
ethylmalonic encephalopathy 1, ETHE1  |
|
lysine-specific histone demethylase 1, LSD1  |
|
checkpoint with forkhead and ring finger domains, CHFR  |
|
peptidyl arginine deiminase type IV, PADI4  |
|
sphingosine-1-phosphate, S1P  |
|
FATS  |
|
interacting with EP300 and NR4A1 (acetylation of NR4A1 is modulated by EP300 and HDAC1, suggesting that acetylation is an important post-translational modification for the rapid turnover of NR4A1 protein)  |
|
SMARCAD1 modulates the interaction of HDAC1 and TRIM28 with heterochromatin  |
|
regulates synergistically with HDAC1 the expression of proinflammatory cytokines and genes of the classical complement pathway  |
|
FAM60A promotes the retention of HDAC1 but not SIN3A at the CCND1 promoter in asynchronously growing cells  |
|
HDAC1, which promotes cellular proliferation and cell cycle progression, antagonizes BHLHE40 sumoylation-dependent growth arrest  |
|
likely HDAC1 functionally interacts with BCOR during eye development and, along with BCL6, act together to mediate normal optic cup formation by preventing colobomata  |
|
TRPS1 interacts with two histone deacetylases, HDAC1 and HDAC4, thereby increasing their activity  |
|
HEXIM1 attenuated the interaction of HIF1A with HDAC1 (histone deacetylase 1), resulting in acetylation of HIF1A  |
|
HLCS acts as a biotin-independent transcriptional repressor interacting with HDAC1, HDAC2 and HDAC7  |
|
SIN3A-associated HDAC1/2-activity is essential for hematopoietic stem cell homeostasis  |
|
SETD6 associated with HDAC1 and MTA2  |
|
IKZF1 and HDAC1 regulate the epigenetic signature in leukemia, via regulation of KDM5B transcription  |
|
BRDT has novel interactions with the histone deacetylase HDAC1, the arginine-specific histone methyltransferase 5 PRMT5, and the Tripartite motif-containing 28 protein TRIM28, and functions in transcriptional repression during spermatogenesis  |
|
SLC6A4 is epigenetically downregulated by HDAC1 in several types of cancer  |
|
catalytic domain of TET3 interacts with HDAC1 and SIN3A, thus enhancing their binding to the IFNB1 promoter  |
|
PHF12 associates with a chromatin interacting protein complex comprised of MORF4L1, SIN3B, and HDAC1, that functions as a transcriptional modulator  |
|
RSF1 interacts with and recruits HDAC1 to centromeres  |
|
USP38 is involved in the DNA damage response (DDR) by regulating the activity of HDAC1  |
|
association of KCTD19 with zinc finger protein 541 (ZNF541) and histone deacetylase 1 (HDAC1)  |